tiprankstipranks
Advertisement
Advertisement

BTAI Stock Latest News

BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
The FlyBioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
7d ago
BTAI
BioXcel Therapeutics Announces Registered Direct Equity Financing
PremiumCompany Announcements
BioXcel Therapeutics Announces Registered Direct Equity Financing
12d ago
8K
BTAI
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe Fly
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
19d ago
BTAI
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
PremiumThe Fly
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
19d ago
BTAI
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
PremiumThe Fly
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
19d ago
BTAI
BTAI Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBTAI Upcoming Earnings Report: What to Expect?
21d ago
BTAI
BioXcel Therapeutics to host KOL roundtable on Alzheimer’s dementia
Premium
The Fly
BioXcel Therapeutics to host KOL roundtable on Alzheimer’s dementia
1M ago
BTAI
BioXcel Highlights IGALMI At-Home Acute Agitation Opportunity
Premium
Company Announcements
BioXcel Highlights IGALMI At-Home Acute Agitation Opportunity
1M ago
8K
BTAI
BioXcel completes updated market opportunity assessment for Igalmi
PremiumThe Fly
BioXcel completes updated market opportunity assessment for Igalmi
1M ago
BTAI
BioXcel sets milestone bonuses amid pivotal IGALMI review
PremiumCompany Announcements
BioXcel sets milestone bonuses amid pivotal IGALMI review
2M ago
8K
BTAI
One new option listing and option delistings on January 20th
PremiumThe Fly
One new option listing and option delistings on January 20th
2M ago
CVM
TEF
BioXcel seeks FDA approval for at-home IGALMI use
PremiumCompany Announcements
BioXcel seeks FDA approval for at-home IGALMI use
2M ago
8K
BTAI
BioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi
PremiumThe FlyBioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi
2M ago
BTAI
BioXcel Therapeutics names interim CCO amid IGALMI expansion
Premium
Company Announcements
BioXcel Therapeutics names interim CCO amid IGALMI expansion
2M ago
8K
BTAI
BioXcel Therapeutics appoints Pavao as acting CCO
Premium
The Fly
BioXcel Therapeutics appoints Pavao as acting CCO
2M ago
BTAI
BioXcel Therapeutics planning to submit sNDA seeking FDA approval for IGALMI
PremiumThe Fly
BioXcel Therapeutics planning to submit sNDA seeking FDA approval for IGALMI
3M ago
BTAI
BioXcel Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
BioXcel Therapeutics Holds Annual Stockholders Meeting
3M ago
8K
BTAI
BioXcel Therapeutics’ Igalmi supplement for new indication approved by FDA
PremiumThe Fly
BioXcel Therapeutics’ Igalmi supplement for new indication approved by FDA
4M ago
BTAI
BioXcel Therapeutics’ Q3 2025 Earnings and Clinical Updates
PremiumCompany Announcements
BioXcel Therapeutics’ Q3 2025 Earnings and Clinical Updates
4M ago
BTAI
BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)
PremiumThe FlyBioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)
4M ago
BTAI
BTAI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
BTAI Earnings this Week: How Will it Perform?
4M ago
BTAI
BioXcel Presents Phase 3 Study on BXCL501
Premium
Company Announcements
BioXcel Presents Phase 3 Study on BXCL501
4M ago
8K
BTAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >